What 4 Analyst Ratings Have To Say About Cellebrite DI
Portfolio Pulse from Benzinga Insights
Four analysts have provided ratings for Cellebrite DI (NASDAQ:CLBT) in the last quarter, with three being bullish and one somewhat bullish. The average price target is $10.25, implying an upside from the current price of $7.89. This average has increased by 36.67% from the previous average price target of $7.50.
August 30, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts are bullish on Cellebrite DI, with an average price target of $10.25, indicating potential upside from the current price.
The bullish sentiment from analysts, along with an increased price target, suggests a positive outlook for Cellebrite DI. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100